Skip to content
PubMed This is a summary of 93 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 93 referenced papers

Top Authors

Peter Henriksen
University of Edinburgh
Jean‐Yves Blay
Centre Léon Bérard
Paolo G. Casali
Fondazione IRCCS Istituto Nazionale dei Tumori
Lisa L. Cunningham
National Institute on Deafness and Other Communication Disorders
Richard Görlick
The University of Texas MD Anderson Cancer Center
Andrew Breglio
National Institutes of Health
Jeremy Whelan
University College London Hospitals NHS Foundation Trust
Sylvie Bonvalot
Institut Curie
Stefan Bielack
Universitätskinderklinik
Jason L. Ferguson
Tripler Army Medical Center

Top Institutions

Ranked by publications Top 10 institutions

References

References (93)
  1. 1

    Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?

    Bertrand TE, Cruz A, Binitie O, et al.

    Clinical orthopaedics and related research 2016; (474(3)):677-83 doi:10.1007/s11999-015-4359-x.

    PMID: 26013153
  2. 2

    Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.

    Sand LG, Szuhai K, Hogendoorn PC

    International journal of molecular sciences 2015; (16(7)):16176-215 doi:10.3390/ijms160716176.

    PMID: 26193259
  3. 3

    [Oncologic therapy of soft tissue sarcoma].

    Tarkkanen M, Lindholm P, Jääskeläinen AS, Sampo M

    Duodecim; laaketieteellinen aikakauskirja 2015; (131(8)):789-95.

    PMID: 26237894
  4. 4

    Chondrosarcoma of the hyoid bone: A diagnostic pitfall in the submandibular region.

    Rito M, Cabrera RA

    Diagnostic cytopathology 2015; (43(11)):933-6 doi:10.1002/dc.23328.

    PMID: 26304473
  5. 5

    Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis.

    Liu F, Zhang Q, Zhu D, et al.

    Medicine 2015; (94(36)):e1462 doi:10.1097/MD.0000000000001462.

    PMID: 26356700
  6. 6

    Osteosarcoma: A Meta-Analysis and Review of the Literature.

    Friebele JC, Peck J, Pan X, et al.

    American journal of orthopedics (Belle Mead, N.J.) 2015; (44(12)):547-53.

    PMID: 26665241
  7. 7

    Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.

    Lorenz S, Barøy T, Sun J, et al.

    Oncotarget 2016; (7(5)):5273-88 doi:10.18632/oncotarget.6567.

    PMID: 26672768
  8. 8

    UK guidelines for the management of bone sarcomas.

    Gerrand C, Athanasou N, Brennan B, et al.

    Clinical sarcoma research 2016; (6()):7 doi:10.1186/s13569-016-0047-1.

    PMID: 27148438
  9. 9

    TP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.

    Chen Z, Guo J, Zhang K, Guo Y

    Disease markers 2016; (2016()):4639575 doi:10.1155/2016/4639575.

    PMID: 27239089
  10. 10

    Effects of resection margins on local recurrence of osteosarcoma in extremity and pelvis: Systematic review and meta-analysis.

    He F, Zhang W, Shen Y, et al.

    International journal of surgery (London, England) 2016; (36(Pt A)):283-292 doi:10.1016/j.ijsu.2016.11.016.

    PMID: 27840310
  11. 11

    Advances in the management of osteosarcoma.

    Bielack SS, Hecker-Nolting S, Blattmann C, Kager L

    F1000Research 2016; (5()):2767 doi:10.12688/f1000research.9465.1.

    PMID: 27990273
  12. 12

    Doxorubicin targets multiple players: A new view of an old problem.

    Cappetta D, Rossi F, Piegari E, et al.

    Pharmacological research 2018; (127()):4-14 doi:10.1016/j.phrs.2017.03.016.

    PMID: 28336372
  13. 13

    Magnetic Resonance Imaging for the Assessment of Long Bone Tumors.

    Jin T, Deng ZP, Liu WF, et al.

    Chinese medical journal 2017; (130(21)):2547-2550 doi:10.4103/0366-6999.217087.

    PMID: 29067953
  14. 14

    Cisplatin is retained in the cochlea indefinitely following chemotherapy.

    Breglio AM, Rusheen AE, Shide ED, et al.

    Nature communications 2017; (8(1)):1654 doi:10.1038/s41467-017-01837-1.

    PMID: 29162831
  15. 15

    Multidisciplinary approach to osteosarcoma.

    Biazzo A, De Paolis M

    Acta orthopaedica Belgica 2016; (82(4)):690-698.

    PMID: 29182106
  16. 16

    Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.

    Henriksen PA

    Heart (British Cardiac Society) 2018; (104(12)):971-977 doi:10.1136/heartjnl-2017-312103.

    PMID: 29217634
  17. 17

    Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study.

    Song K, Shi X, Liang X, et al.

    International orthopaedics 2018; (42(12)):2941-2948 doi:10.1007/s00264-018-3942-7.

    PMID: 29681020
  18. 18

    Understanding osteosarcomas.

    Simpson E, Brown HL

    JAAPA : official journal of the American Academy of Physician Assistants 2018; (31(8)):15-19 doi:10.1097/01.JAA.0000541477.24116.8d.

    PMID: 29979330
  19. 19

    Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.

    Fukushima T, Ogura K, Akiyama T, et al.

    BMC musculoskeletal disorders 2018; (19(1)):297 doi:10.1186/s12891-018-2217-1.

    PMID: 30121085
  20. 20

    Bone Cancer: Diagnosis and Treatment Principles.

    Ferguson JL, Turner SP

    American family physician 2018; (98(4)):205-213.

    PMID: 30215968
  21. 21

    Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    Casali PG, Bielack S, Abecassis N, et al.

    Annals of oncology : official journal of the European Society for Medical Oncology 2018; (29(Suppl 4)):iv79-iv95 doi:10.1093/annonc/mdy310.

    PMID: 30285218
  22. 22

    Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.

    Trendowski MR, El Charif O, Dinh PC, et al.

    Clinical cancer research : an official journal of the American Association for Cancer Research 2019; (25(4)):1147-1155 doi:10.1158/1078-0432.CCR-18-2244.

    PMID: 30305294
  23. 23

    Variations in contents of hyaluronan in the peritumoral micro-environment of human chondrosarcoma.

    Fede C, Stecco C, Angelini A, et al.

    Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2019; (37(2)):503-509 doi:10.1002/jor.24176.

    PMID: 30444002
  24. 24

    Osteosarcoma and second malignant neoplasms: a case series.

    Geary RL, Corrigan LR, Carney DN, Higgins MJ

    Irish journal of medical science 2019; (188(4)):1163-1167 doi:10.1007/s11845-019-02027-2.

    PMID: 31054046
  25. 25

    Surgery in reference centers improves survival of sarcoma patients: a nationwide study.

    Blay JY, Honoré C, Stoeckle E, et al.

    Annals of oncology : official journal of the European Society for Medical Oncology 2019; (30(7)):1143-1153 doi:10.1093/annonc/mdz124.

    PMID: 31081028
  26. 26

    Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.

    Song K, Song J, Lin K, et al.

    International orthopaedics 2019; (43(8)):1983-1991 doi:10.1007/s00264-019-04348-4.

    PMID: 31127366
  27. 27

    Treatment-Related Prognostic Factors in Managing Osteosarcoma around the Knee with Limb Salvage Surgery: A Lesson from a Long-Term Follow-Up Study.

    Hu J, Zhang C, Zhu K, et al.

    BioMed research international 2019; (2019()):3215824 doi:10.1155/2019/3215824.

    PMID: 31187043
  28. 28

    Surgical and Psychosocial Predictors of Mental Health in Parents of Children With Cardiac Admissions.

    Stokes JR, Muscara F, Zannino D, et al.

    The Annals of thoracic surgery 2020; (110(5)):1677-1682 doi:10.1016/j.athoracsur.2020.01.072.

    PMID: 32147414
  29. 29

    Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.

    Tsuda Y, Tsoi K, Parry MC, et al.

    The bone & joint journal 2020; (102-B(6)):795-803 doi:10.1302/0301-620X.102B6.BJJ-2019-1307.R1.

    PMID: 32475245
  30. 30

    Adjuvant and Neoadjuvant Chemotherapy for Osteosarcoma: A Historical Perspective.

    Benjamin RS

    Advances in experimental medicine and biology 2020; (1257()):1-10 doi:10.1007/978-3-030-43032-0_1.

    PMID: 32483726
  31. 31

    Cumulative Burden of Chronic Health Conditions in Adult Survivors of Osteosarcoma and Ewing Sarcoma: A Report from the St. Jude Lifetime Cohort Study.

    Bishop MW, Ness KK, Li C, et al.

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020; (29(8)):1627-1638 doi:10.1158/1055-9965.EPI-20-0076.

    PMID: 32499311
  32. 32

    Percutaneous Imaging-Guided versus Open Musculoskeletal Biopsy: Concepts and Controversies.

    Vasilevska Nikodinovska V, Ivanoski S, Samardziski M, Janevska V

    Seminars in musculoskeletal radiology 2020; (24(6)):667-675 doi:10.1055/s-0040-1717113.

    PMID: 33307583
  33. 33

    Prediction of soft tissue coverage following distal femur bone sarcoma resection: A preliminary report.

    Baysal Ö, Sağlam F, Akgülle AH, et al.

    Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2022; (40(2)):468-474 doi:10.1002/jor.25030.

    PMID: 33713479
  34. 34

    Factors Affecting Prognosis and Survival in Extremity Osteosarcoma.

    Dharanikota A, Arjunan R, Dasappa A

    Indian journal of surgical oncology 2021; (12(1)):199-206 doi:10.1007/s13193-020-01277-2.

    PMID: 33814854
  35. 35

    Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.

    Prabowo Y, Setiawan I, Kamal AF, et al.

    International journal of surgical oncology 2021; (2021()):8843325 doi:10.1155/2021/8843325.

    PMID: 33996154
  36. 36

    Needle tract seeding following percutaneous biopsy of pediatric head and neck sarcoma: A case report.

    You P, Haynes DA, Desai S, et al.

    Clinical case reports 2021; (9(5)):e04074 doi:10.1002/ccr3.4074.

    PMID: 34084495
  37. 37

    Clinical Statistical Analysis with Comparison between Pelvic and Non-pelvic Chondrosarcoma.

    Jami SA, Jiandang S, Roy BS, et al.

    Oman medical journal 2021; (36(3)):e271 doi:10.5001/omj.2021.65.

    PMID: 34239712
  38. 38

    Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial.

    Ghonaim E, El-Haggar S, Gohar S

    Medical oncology (Northwood, London, England) 2021; (38(9)):108 doi:10.1007/s12032-021-01558-y.

    PMID: 34357466
  39. 39

    Local Lung Mass Masquerading a Very Aggressive Extraskeletal Ewing Sarcoma Presenting as Bilateral Paraparesis in a Young Adult.

    Pokal M, Sangani V, Balla M, et al.

    Journal of medical cases 2020; (11(12)):388-393 doi:10.14740/jmc3582.

    PMID: 34434351
  40. 40

    Diagnosis and staging of malignant bone tumours in children: what is due and what is new?

    Salom M, Chiari C, Alessandri JMG, et al.

    Journal of children's orthopaedics 2021; (15(4)):312-321 doi:10.1302/1863-2548.15.210107.

    PMID: 34476020
  41. 41

    Primary diffuse large B-cell lymphoma of the bone mimicking osteomyelitis.

    Mofidi A, Esfandbod M, Pendar E, et al.

    Clinical case reports 2021; (9(9)):e04724 doi:10.1002/ccr3.4724.

    PMID: 34484760
  42. 42

    The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.

    Kinoshita H, Shimozato O, Ishii T, et al.

    Anticancer research 2021; (41(10)):4947-4955 doi:10.21873/anticanres.15308.

    PMID: 34593442
  43. 43

    One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.

    Flores G, Grohar PJ

    Journal of bone oncology 2021; (31()):100404 doi:10.1016/j.jbo.2021.100404.

    PMID: 34976713
  44. 44

    Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma.

    Wu F, Xu J, Jin M, et al.

    Frontiers in molecular biosciences 2021; (8()):705148 doi:10.3389/fmolb.2021.705148.

    PMID: 35071320
  45. 45

    Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis.

    Wang J, Tang J, Tan X, et al.

    Frontiers in surgery 2022; (9()):817051 doi:10.3389/fsurg.2022.817051.

    PMID: 35223978
  46. 46

    Osteosarcoma: A Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017.

    Cole S, Gianferante DM, Zhu B, Mirabello L

    Cancer 2022; (128(11)):2107-2118 doi:10.1002/cncr.34163.

    PMID: 35226758
  47. 47

    Role of Individual, Family, and Community Resilience in Moderating Effects of Adverse Childhood Experiences on Mental Health Among Children.

    Okwori G

    Journal of developmental and behavioral pediatrics : JDBP 2022; (43(7)):e452-e462 doi:10.1097/DBP.0000000000001076.

    PMID: 35385422
  48. 48

    Single-Cell Profiling of Tumor Microenvironment Heterogeneity in Osteosarcoma Identifies a Highly Invasive Subcluster for Predicting Prognosis.

    Guo J, Tang H, Huang P, et al.

    Frontiers in oncology 2022; (12()):732862 doi:10.3389/fonc.2022.732862.

    PMID: 35463309
  49. 49

    Efficacy of Neoadjuvant Chemotherapy plus Limb-Sparing Surgery for Osteosarcoma and Its Impact on Long-Term Quality of Life.

    Jing S, Ding F, Yuan Y, et al.

    Evidence-based complementary and alternative medicine : eCAM 2022; (2022()):1693824 doi:10.1155/2022/1693824.

    PMID: 35978993
  50. 50

    Systemic treatment for primary malignant sarcomas arising in craniofacial bones.

    Bielack SS

    Frontiers in oncology 2022; (12()):966073 doi:10.3389/fonc.2022.966073.

    PMID: 36158667
  51. 51

    Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.

    Cederberg KB, Iyer RS, Chaturvedi A, et al.

    Pediatric blood & cancer 2023; (70 Suppl 4()):e30000 doi:10.1002/pbc.30000.

    PMID: 36250990
  52. 52

    Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.

    Brennan B, Kirton L, Marec-Bérard P, et al.

    Lancet (London, England) 2022; (400(10362)):1513-1521 doi:10.1016/S0140-6736(22)01790-1.

    PMID: 36522207
  53. 53

    Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment.

    Goedhart LM, Ho VKY, Ploegmakers JJW, et al.

    Journal of bone oncology 2023; (38()):100466 doi:10.1016/j.jbo.2022.100466.

    PMID: 36578650
  54. 54

    Case report and literature review: Primary leiomyosarcoma of the bone in the trochanteric region of the femur.

    Wu Z, Cheng L, Cao Q, et al.

    Frontiers in surgery 2022; (9()):1045307 doi:10.3389/fsurg.2022.1045307.

    PMID: 36704525
  55. 55

    Molecular and Translational Research on Bone Tumors.

    Rossi M, Del Fattore A

    International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24031946.

    PMID: 36768270
  56. 56

    Prognostic analysis of telangiectatic osteosarcoma of the extremities.

    Zhong W, Luo W, Lin Z, et al.

    Frontiers in oncology 2022; (12()):1105054 doi:10.3389/fonc.2022.1105054.

    PMID: 36815074
  57. 57

    The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.

    Tzelnick S, Soroka HP, Tasnim N, et al.

    Oral oncology 2023; (145()):106495 doi:10.1016/j.oraloncology.2023.106495.

    PMID: 37478572
  58. 58

    Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.

    Zając W, Dróżdż J, Kisielewska W, et al.

    Cancers 2023; (15(15)) doi:10.3390/cancers15153924.

    PMID: 37568740
  59. 59

    Recognizing and treating patients with Ewing sarcoma.

    Windheuser A, Gardner N

    JAAPA : official journal of the American Academy of Physician Assistants 2023; (36(9)):1-4 doi:10.1097/01.JAA.0000937324.58262.55.

    PMID: 37668491
  60. 60

    A meta-analysis of the efficacy and safety of first-line chemotherapeutic agents for osteosarcoma.

    Li Z, Ma X, Wang Z, et al.

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2024; (33(5)):445-454 doi:10.17219/acem/170098.

    PMID: 37747442
  61. 61

    Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.

    Saba KH, Difilippo V, Kovac M, et al.

    The Journal of pathology 2024; (262(2)):147-160 doi:10.1002/path.6219.

    PMID: 38010733
  62. 62

    Does an excision of needle bone biopsy tract affect the prognosis in patients with primary bone tumor?

    Gami A, Shah A, Shankaralingappa S, et al.

    Journal of orthopaedics 2024; (48()):13-19 doi:10.1016/j.jor.2023.11.039.

    PMID: 38059219
  63. 63

    The significance of surveillance imaging in children with Ewing sarcoma and osteosarcoma.

    Brekke SG, Lucke A, Hasle H, Baad-Hansen T

    Pediatric hematology and oncology 2024; (41(4)):273-282 doi:10.1080/08880018.2024.2311407.

    PMID: 38345039
  64. 64

    Care Models and Barriers to Long-Term Follow-Up Care Among Childhood Cancer Survivors and Health Care Providers in Asia: A Literature Review.

    Cai J, Cheung YT, Hudson MM

    JCO global oncology 2024; (10()):e2300331 doi:10.1200/GO.23.00331.

    PMID: 38452303
  65. 65

    Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.

    Anderson AB, Kim E, Park AB, et al.

    The Journal of the American Academy of Orthopaedic Surgeons 2024; (32(13)):e651-e660 doi:10.5435/JAAOS-D-23-00897.

    PMID: 38684126
  66. 66

    Bone Radiation-Induced Sarcomas: Outcomes Based on Histology and Surgical Treatment: A Systematic Review of the Literature.

    Inchaustegui ML, Larios F, Buteau JP, et al.

    JBJS reviews 2024; (12(8)) doi:10.2106/JBJS.RVW.24.00066.

    PMID: 39102470
  67. 67

    Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury.

    Avagimyan A, Pogosova N, Kakturskiy L, et al.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2024; (73()):107683 doi:10.1016/j.carpath.2024.107683.

    PMID: 39111556
  68. 68

    Histopathological Response to Neoadjuvant Chemotherapy in Patients With Enneking Stage II Conventional Osteosarcoma of Extremities: A Retrospective-Single Institution Study in Vietnam.

    Do KH, Nguyen TV, Hoang TT, et al.

    Cancer control : journal of the Moffitt Cancer Center 2024; (31()):10732748241274188 doi:10.1177/10732748241274188.

    PMID: 39183728
  69. 69

    Patient-specific guides for consistently achieving R0 bone margins after resection of primary malignant bone tumors of the pelvis.

    du Cluzel de Remaurin X, Dumaine V, Cladiere-Nassif V, et al.

    World journal of surgical oncology 2024; (22(1)):233 doi:10.1186/s12957-024-03478-3.

    PMID: 39232698
  70. 70

    UK guidelines for the management of bone sarcomas.

    Gerrand C, Amary F, Anwar HA, et al.

    British journal of cancer 2025; (132(1)):32-48 doi:10.1038/s41416-024-02868-4.

    PMID: 39550489
  71. 71

    Limb Salvage Surgery in Pediatric Patients with Osteosarcoma.

    Niculescu ȘA, Grecu AF, Gheonea C, Grecu DC

    Current health sciences journal 2024; (50(3)):360-367 doi:10.12865/CHSJ.50.03.03.

    PMID: 39574503
  72. 72

    Examining Interventions for Pediatric Adverse Childhood Experiences in an Integrated Primary Care Setting.

    Rosado JI, Gabany S, Fortino M, Fernandez-Garcia A

    Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2025; (39(2)):155-163 doi:10.1016/j.pedhc.2024.10.015.

    PMID: 39580746
  73. 73

    Determinants of tumor necrosis and its impact on outcome in patients with Localized osteosarcoma uniformly treated with a response adapted regimen without high dose Methotrexate- A retrospective institutional analysis.

    Roy PG, Ganguly S, Sasi A, et al.

    Journal of bone oncology 2024; (49()):100651 doi:10.1016/j.jbo.2024.100651.

    PMID: 39687212
  74. 74

    Evaluation of the Diagnostic Accuracy of Percutaneous Core Needle Biopsy in Bone and Soft Tissue Tumors.

    Cengiz T, Yurtbay A, Muslu O, et al.

    Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 2024; (91(6)):376-384 doi:10.55095/ACHOT2024/042.

    PMID: 39781639
  75. 75

    Predictive Factors for Lung Metastasis in High-Grade Osteosarcoma: A 5 Years Experience from Tertiary Referral Hospital.

    Prabowo Putro YA, Magetsari R, Oksikimbawan Tampubolon Y, et al.

    Acta orthopaedica Belgica 2024; (90(4)):739-743 doi:10.52628/90.4.12808.

    PMID: 39869878
  76. 76

    Amputation Versus Limb-Salvage Surgery as Treatments for Pediatric Bone Sarcoma: A Comparative Study of Survival, Function, and Quality of Life.

    Vale SS, Castro R, Andrade A, et al.

    Cureus 2025; (17(2)):e78543 doi:10.7759/cureus.78543.

    PMID: 40062064
  77. 77

    Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets.

    Wagner MJ, Pimenta EM, Sweeney NW, et al.

    JCO precision oncology 2025; (9()):e2400592 doi:10.1200/PO-24-00592.

    PMID: 40117529
  78. 78

    Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

    Biermann JS, Hirbe A, Ahlawat S, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2025; (23(4)).

    PMID: 40203873
  79. 79

    Post-treatment late and long-term effects in bone sarcoma: A scoping review.

    Khan K, Kane K, Davison Z, Green D

    Journal of bone oncology 2025; (52()):100671 doi:10.1016/j.jbo.2025.100671.

    PMID: 40206491
  80. 80

    Survivorship therapy needs after radiotherapy for head and neck cancer: surveying opportunities for growth (STRONG).

    Larson A, Ma Y, Sun Z, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025; (33(5)):403 doi:10.1007/s00520-025-09429-2.

    PMID: 40299080
  81. 81

    Imaging features at the time of diagnosis of osteosarcoma and Ewing sarcoma in children.

    Moreno-Reina C, Bueno-Gómez M, Guitiérrez-Carrasco JI, Caro-Domínguez P

    Radiologia 2025; (67(3)):253-262 doi:10.1016/j.rxeng.2023.11.003.

    PMID: 40412839
  82. 82

    Epidemiology and Chemosensitivity of Primary Malignant Bone Tumors at a Teaching Hospital in South Africa: A 5-Year Retrospective Analysis.

    Kgagudi MP, Ramokgopa MT, Jingo M

    Medical science monitor : international medical journal of experimental and clinical research 2025; (31()):e948274 doi:10.12659/MSM.948274.

    PMID: 40758634
  83. 83

    Survivorship care and mortality in a contemporary and diverse cohort of childhood cancer survivors.

    Ji X, Williamson Lewis RS, Wasilewski-Masker K, et al.

    Journal of the National Cancer Institute 2025; doi:10.1093/jnci/djaf276.

    PMID: 41002187
  84. 84

    New cell lines expanding the diversity of Ewing sarcoma models.

    Kerkhoff M, Schaefer C, Dirks WG, et al.

    International journal of cancer 2026; (158(3)):642-655 doi:10.1002/ijc.70172.

    PMID: 41002248
  85. 85

    EWS::FLI1 expression in human embryonic mesenchymal stem cells leads to transcriptional reprograming, defective DNA damage repair and Ewing sarcoma.

    Hernández-Muñoz I, Cuervas I, Prada E, et al.

    Nature communications 2025; (16(1)):9427 doi:10.1038/s41467-025-64475-y.

    PMID: 41136396
  86. 86

    Magnetic resonance imaging features of primary appendicular bone sarcomas in 20 dogs.

    Sapet J, Gatel L, Floch F, Vanel M

    The Journal of small animal practice 2026; (67(4)):343-352 doi:10.1111/jsap.70070.

    PMID: 41387098
  87. 87

    The hegemonic EWSR1::ETS oncoprotein overrules core regulatory circuitry principles in Ewing sarcoma.

    Grossetete S, Zaidi S, Orth MF, et al.

    NPJ precision oncology 2025; doi:10.1038/s41698-025-01226-8.

    PMID: 41444391
  88. 88

    DISTAL (Distal tibia tumors treated with amputation versus limb Salvage): A systematic review and meta-analysis of oncologic, functional, and complication outcomes in malignant bone tumors.

    Garg N, Menon PH, Bajaj SK, et al.

    Journal of orthopaedics 2026; (73()):21-29 doi:10.1016/j.jor.2025.11.018.

    PMID: 41458943
  89. 89

    Self-disclosure dynamics in psychological crisis among Chinese pediatric patients with severe nocturnal enuresis: A qualitative inquiry.

    Xie B, Sun XR, Wang X, Xu YN

    Journal of family medicine and primary care 2025; (14(12)):5066-5071 doi:10.4103/jfmpc.jfmpc_376_25.

    PMID: 41624677
  90. 90

    Long-term Outcomes of 3-dimensional-printed Cutting Guides for Long Bone Sarcoma Resection and Intercalary Allograft Reconstruction: An Updated Case Series.

    Butler ZR, Riley DJ, Gusho CA, et al.

    Orthopedics 2026; (49(1)):e76-e82 doi:10.3928/01477447-20260106-02.

    PMID: 41636431
  91. 91

    PATIENTS WITH SOFT TISSUE SARCOMA AFTER TREATMENT BY NON ORTHOPEDIC ONCOLOGIC SURGEONS: EPIDEMIOLOGICAL PROFILE, STAGING, AND THERAPEUTIC CHALLENGES.

    do Couto FB, Yonamine ES, Magno FG, et al.

    Acta ortopedica brasileira 2026; (34(1)):e293900 doi:10.1590/1413-785220263401e293900.

    PMID: 41696555
  92. 92

    Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription.

    Kaufman R, Flores G, Boguslawski EA, et al.

    Nature communications 2026; (17(1)).

    PMID: 41698909
  93. 93

    Undifferentiated Small Round Cell Sarcomas: Radiologic-Pathologic Correlation for the Updated WHO Classification Fifth Edition (2020).

    Mori K, Kurokawa R, Motoi T, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2026; (46(4)):e250087 doi:10.1148/rg.250087.

    PMID: 41886300